04/27/2011
Christopher A. Chapleau, PhD; J. Mark Westfall, MD; David R. Luthin, PhD; Marshall E. Cates, PharmD, BCPP, FASHP
<div id="article-content-body">
<p><strong>Abstract: Selective serotonin reuptake inhibitors and other second-generation antidepressants have become common therapeutic options...
